Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis

Neuroreport. 1994 Nov 21;5(17):2301-4. doi: 10.1097/00001756-199411000-00024.

Abstract

Sulphated cholecystokinin-8 (CCK-8) given into the neostriatum of the rat by in vivo microdialysis produced a concentration-dependent (1-100 microM) increase in extracellular aspartate (Asp) and dynorphin B (Dyn B), but not in glutamate, GABA or dopamine levels. The increase in Asp levels produced by 10 microM CCK-8 was approximately 10 fold and was inhibited (approximately 50%) by the CCKB antagonist L-365,260 (20 mg kg-1, i.p.), while the increase in Dyn B (approximately 2 fold) was totally abolished. Both increases were inhibited (approximately 50%) by local infusion of 10 microM of tetrodotoxin (TTX). Thus, CCK exerts modulatory effects in the basal ganglia, possibly by interacting with local neostriatal neurones releasing Asp, and with Dyn B-containing neurones projecting to the pars reticulata of the substantia nigra.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aspartic Acid / antagonists & inhibitors
  • Aspartic Acid / metabolism*
  • Benzodiazepinones / pharmacology
  • Corpus Striatum / metabolism*
  • Dynorphins / antagonists & inhibitors
  • Dynorphins / metabolism*
  • Endorphins / antagonists & inhibitors
  • Endorphins / metabolism*
  • Male
  • Microdialysis
  • Phenylurea Compounds*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Cholecystokinin / antagonists & inhibitors
  • Sincalide / pharmacology*
  • Tetrodotoxin / pharmacology

Substances

  • Benzodiazepinones
  • Endorphins
  • Phenylurea Compounds
  • Receptors, Cholecystokinin
  • Aspartic Acid
  • L 365260
  • Tetrodotoxin
  • Dynorphins
  • rimorphin
  • Sincalide